Long lasting effect of new botulinum toxin formulations
US12377137B2 · kind B2 · utility
0Cited by
21References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2024 |
| Grant date | Aug 5, 2025 |
| Priority date | — |
| Expiry date | Apr 12, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.